24h
Current
Min
10.84
Max
13.5
Income | -17K -9.4M |
---|---|
EPS | -0.248 |
Employees | 288 |
EBITDA | 262K -3.9M |
Next Earnings | 26 Sept 2025 |
---|
Market Cap | 83M 291M |
---|---|
Previous open | -3.95 |
Previous close | 12.9 |
Past performance is not a reliable indicator of future results.
4 Aug 2025, 21:42 UTC
Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone
DJ
Read
4 Aug 2025, 21:21 UTC
Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update
DJ
Read
4 Aug 2025, 20:45 UTC
Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb
DJ
Read
4 Aug 2025, 19:15 UTC
TransMedics Group Shares Rise on FDA Approval for Clinical Trial
DJ
Read
4 Aug 2025, 23:41 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
4 Aug 2025, 23:41 UTC
Nikkei May Rise on Fed Stimulus Hopes
DJ
Read
4 Aug 2025, 23:28 UTC
Global Equities Roundup: Market Talk
DJ
Read
4 Aug 2025, 23:28 UTC
Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk
DJ
Read
4 Aug 2025, 21:30 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com
DJ
Read
4 Aug 2025, 21:21 UTC
Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com
DJ
Read
4 Aug 2025, 21:18 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com
DJ
Read
4 Aug 2025, 20:25 UTC
India Hits Back Over Russian Oil Purchases -- Market Talk
DJ
Read
4 Aug 2025, 20:25 UTC
Transocean 2Q Loss $938M >RIG
DJ
Read
4 Aug 2025, 20:25 UTC
Transocean 2Q Loss/Shr $1.06 >RIG
DJ
Read
4 Aug 2025, 20:18 UTC
Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com
DJ
Read
4 Aug 2025, 20:15 UTC
Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX
DJ
Read
4 Aug 2025, 20:14 UTC
Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX
DJ
Read
4 Aug 2025, 20:14 UTC
Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX
DJ
Read
4 Aug 2025, 20:14 UTC
Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX
DJ
Read
4 Aug 2025, 20:13 UTC
Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX
DJ
Read
4 Aug 2025, 20:09 UTC
Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM
DJ
Read
4 Aug 2025, 20:06 UTC
Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Net $1.03B >VRTX
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX
DJ
Read
4 Aug 2025, 20:01 UTC
Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX
DJ
Read
4 Aug 2025, 19:41 UTC
U.S. Natural Gas Futures Settle Lower -- Market Talk
DJ
Read
4 Aug 2025, 19:28 UTC
U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk
DJ
Read
4 Aug 2025, 19:07 UTC
Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk
DJ
Read
4 Aug 2025, 18:27 UTC
Gold Climbs on Rate Cut Speculation -- Market Talk
DJ
Read
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$